All Skin Cancer OI Articles

Early diagnosis and timely referral to oncology are crucial for patients with advanced non-melanoma skin cancer to improve their clinical outcomes, treatment opportunities, and quality of life.

ACCC conducted a series of virtual workshops to engage members of the multidisciplinary care team on effective practices for supporting, treating, and managing patients with advanced cutaneous non-melanoma skin cancers.

For detailed information about planning a skin cancer screening, download the Academy’s Plan an Event Toolkit at www.SpotSkinCancer.org.

In 2016, Valley Health, a not-for-profit healthcare system serving patients in Maryland, Virginia, and West Virginia, partnered with a local dermatology office and various community and state stakeholders on a common goal to educate our community about smart sun protection decisions and the importance of skin cancer screenings.

The ultimate goal of the new Skin Cancer Screening Clinic: to generate volume, community awareness, and new revenue for the hospital.

The only standard treatments for metastatic melanoma that have been associated with long-term overall survival (OS) are surgical resection, and immunotherapies that include the immune-stimulating cytokine interleukin-2 (IL2), the anticytotoxic T lymphocyte antigen-4 (CTLA-4) monoclonal antibody ipilimumab, and the anti-programmed death 1 (PD1) monoclonal antibodies nivolumab and pembrolizumab (aka lambrolizumab).

While young people across the U.S. are able to access more information through technology with greater speed, they may be misinformed or lack understanding of how unhealthy behaviors can put their health at risk.

Fox Chase Cancer Center, Philadelphia, Pa., committed resources to develop a program to improve communication and education between oncology and primary care, and improve overall survivorship care.